2023-11-10T14:22:10-06:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP 227 WEST TRADE STREET SUITE 800 CHARLOTTE NC 28202 990 2022-01-01 010648145 ORTHOCAROLINA RESEARCH INSTITUTE INC ORTH 7043232260 2001 VAIL AVENUE SUITE 300 CHARLOTTE NC 28207 CHRISTI CADD EXECUTIVE DIRECTOR 7043232260 2023-11-09 1 CHRISTI CADD 999009999 0 JOHN NORMAN P01506766 7049985200 2023-10-31 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z CHRISTI CADD 2001 VAIL AVENUE SUITE 300 CHARLOTTE NC 28207 1579440 0 X WWW.ORTHOCAROLINARESEARCH.ORG X 2002 NC TO PROMOTE, DEVELOP AND CONDUCT STATE OF THE ART SCIENTIFIC RESEARCH AND EDUCATIONAL PROGRAMS FOR THE ADVANCEMENT OF ORTHOPEDIC CARE. OCRI WORKS BOTH INDEPENDENTLY AS WELL AS IN COLLABORATIONS WITH UNIVERSITIES, HOSPITALS, PHARMACEUTICAL AND DEVICE COMPANIES AND OTHER ACADEMIC AND RESEARCH ORGANIZATIONS TO FURTHER PROMOTE THE MISSION. 16 16 0 15 0 0 2015726 945893 889967 633547 0 0 -6126 0 2899567 1579440 160000 131381 0 0 0 0 0 0 13271 2091473 1907882 2251473 2039263 648094 -459823 4697920 3834315 277447 355745 4420473 3478570 X THE ORTHOCAROLINA RESEARCH INSTITUTE (OCRI) IS AN INDEPENDENT, NON-PROFIT 501(C)3 THAT EXISTS TO FACILITATE RELEVANT ORTHOPEDIC RESEARCH WHICH ADVANCES ORTHOPEDIC TREATMENTS, IMPROVES QUALITY OF LIFE FOR PATIENTS, AND EDUCATES THE MEDICAL COMMUNITY. 0 0 1336073 633547 THE INSTITUTE'S MISSION AND PRIORITIES ARE CENTRALLY FOCUSED ON (1) IMPROVED ORTHOPEDIC PATIENT CARE AND (2) HIGH QUALITY EVIDENCE-BASED RESEARCH TO DEVELOP NEW AND INNOVATIVE ORTHOPEDIC DEVICES AND TECHNOLOGIES WHOSE GOAL IS TO ANSWER CLINICAL QUESTIONS FOR IMPROVED OUTCOMES. THE INSTITUTE LEADS ONGOING FDA-REGULATED CLINICAL TRIALS AND INVESTIGATOR-INITIATED SCIENTIFIC ACADEMIC STUDIES. RESEARCH IS DISSEMINATED THROUGH PEER REVIEWED JOURNAL PUBLICATIONS WITH GREATER THAN 85 PUBLICATIONS ANNUALLY. 131381 131381 OPERATION WALK CAROLINAS PROVIDES HIP AND KNEE JOINT REPLACEMENT SURGERIES AT NO COST TO PATIENTS IN UNDERSERVED COUNTRIES WHO HAVE NO ACCESS TO THIS LEVEL OF CARE. IN ADDITION, THE MEDICAL TEAM SPENDS TIME TEACHING THE ORTHOPEDIC SURGEONS, NURSES, PHYSICAL THERAPISTS AND OTHER HEALTHCARE PROFESSIONALS IN THAT COUNTRY ON THE MOST ADVANCED TECHNIQUES AND TREATMENTS FOR DISEASES OF THE HIP AND KNEE JOINTS IN ORDER TO BETTER SERVE THEIR PATIENTS. HEALTHCARE PROFESSIONALS FROM THE CHARLOTTE AREA NON-PROFIT HOSPITAL SYSTEMS COLLABORATE WITH THE ORTHOCAROLINA PHYSICIAN TEAM TO COMPLETE SURGERIES ON THOSE MOST SEVERE CASES. 82602 THE INSTITUTE'S MISSION IS FOCUSED ON ADVANCING BOTH RESEARCH AND EDUCATION IN ORTHOPEDICS. THE ORTHOCAROLINA RESEARCH INSTITUTE HOSTS AN EDUCATIONAL CME (CONTINUING MEDICAL EDUCATION) SYMPOSIUM, KNOWN AS OSCAR MILLER DAY, FOR 350-400 ORTHOPEDIC PROVIDERS AND ALLIED HEALTH CARE PROFESSIONALS EACH YEAR. THIS SYMPOSIUM IS OVER 40 YEARS OLD AND IS MARKETED TO THE SOUTHEASTERN U.S. TOPICS ARE ROTATED ANNUALLY. 10102 ARMS FOR ALL IS A PROGRAM UNDER OCRI THAT COVERS THE GAP EXPENSE BETWEEN WHAT INSURANCE WILL COVER AND WHAT IS THE BEST PROSTHETIC FOR IMPROVED QUALITY OF LIFE FOR PATIENTS WHO HAVE LOST A LIMB. 10102 1560158 1 1 0 0 0 0 0 1 0 0 1 1 0 0 1 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 SC X CHRISTI CADD 7043232260 2001 VAIL AVENUE SUITE 300 CHARLOTTE NC 28207 WILLIAM GRIFFIN MD BOARD DIRECTOR 0.10 X X 0 0 0 PATRICK M CONNOR BOARD DIRECTOR 0.10 X 0 0 0 WALTER B BEAVER MD BOARD DIRECTOR 0.10 X 0 0 0 JOHN L FRALEY JR BOARD DIRECTOR 0.10 X 0 0 0 RICHARD E THIGPEN BOARD DIRECTOR 0.10 X 0 0 0 FRED R JONES BOARD DIRECTOR 0.50 X 0 0 0 MORRY JOHNSTON BOARD DIRECTOR 0.10 X 0 0 0 CLENN GASTON MD CHAIRMAN 2.00 X X 0 0 0 CHARLES EAST III BOARD DIRECTOR 0.50 X 0 0 0 BRANDON BOYD BOARD DIRECTOR 0.10 X 0 0 0 VELVA WOOLEN BOARD DIRECTOR 0.10 X 0 0 0 HARVEY GANTT BOARD DIRECTOR 0.10 X 0 0 0 BRUCE DARDEN MD BOARD DIRECTOR 0.50 X X 0 0 0 KENT ELLINGTON MD BOARD DIRECTOR 0.10 X 0 0 0 JOE HSU MD BOARD DIRECTOR 0.10 X 0 0 0 TOM SMITH BOARD DIRECTOR 0.50 X 0 0 0 CHRISTI CADD EXECUTIVE DIRECTOR 45.00 X 133342 0 0 133342 0 0 1 0 0 0 0 945893 7882 945893 RESEARCH INCOME 541700 633547 633547 633547 1579440 633547 0 0 131381 131381 29113 29113 2078 2078 7057 7057 40522 40522 5709 722 4987 23319 23319 PAYROLL REIMBURSEMENT 1424598 1133607 290991 STUDY EXPENSES 200390 200390 OSCAR MILLER DAY EXPENS 82602 82602 ARMS FOR ALL 10102 10102 82392 1354 67767 13271 2039263 1560158 465834 13271 501818 465189 5087 5089 700000 300000 391756 438318 34967 31196 63378 63378 0 0 3048292 2508522 16000 86001 4697920 3834315 277447 285744 0 70001 277447 355745 X 3014342 2180207 1406131 1298363 4420473 3478570 4697920 3834315 X -459823 5404 -487484 X 0 1 X 1 0 X 1118534 1804808 1258438 2015726 945893 7143399 863132 1383549 748260 889967 633547 4518455 1981666 3188357 2006698 2905693 1579440 11661854 691190 624256 509022 541573 233001 2599042 8524 352082 235526 596132 699714 624256 861104 777099 233001 3195174 8466680 10 14 5 29 10 14 5 29 5000 5000 1981676 3188371 2006703 2910693 1579440 11666883 0.72570 0.63890 0.00000 0.02740 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 16000 16000 X 0 1 13878 13878 0 49500 49500 0 0 BENEFICIAL INTEREST IN POOLED FUNDS 2508522 F 2508522 CURRENT LEASE LIABILITY 34144 LEASE LIABILITY, NET OF CURRENT PORTION 35857 70001 X 1584844 5404 5404 1579440 0 1579440 2039263 0 2039263 0 2039263 PART III, LINE 4: A GRATEFUL PATIENT GIFTED A PIECE OF GLASS ART WITH A $16,000 APPRAISED VALUE IN HONOR OF DR. WALTER BEAVER TO THE ORTHOCAROLINA RESEARCH INSTITUTE. IT IS DISPLAYED IN THE PATIENT WAITING ROOM. IT HAS NO RELAVENCE TO THE ORGANIZATIONS MISSION. PART V, LINE 4: FOUNDATION FOR THE CAROLINAS, AN UNRELATED CHARITABLE ORGANIZATION, HOLDS POOLED FUNDS ON BEHALF OF THE INSTITUTE. THOSE FUNDS GENERATE INVESTMENT INCOME THAT IS USED FOR THE GENERAL SUPPORT OF THE INSTITUTE'S PROGRAM ACTIVITIES. PART X, LINE 2: THE INSTITUTE ADOPTED FASB GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE GUIDANCE CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS BY PRESCRIBING A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN. THE INSTITUTE'S POLICY IS TO RECORD A LIABILITY FOR ANY TAX POSITION TAKEN THAT IS BENEFICIAL TO THE INSTITUTE, INCLUDING ANY RELATED INTEREST AND PENALTIES, WHEN IT IS MORE LIKELY THAN NOT THE POSITION TAKEN BY MANAGEMENT WITH RESPECT TO A TRANSACTION OR CLASS OF TRANSACTIONS WILL BE OVERTURNED BY A TAXING AUTHORITY UPON EXAMINATION. MANAGEMENT BELIEVES THERE ARE NO SUCH POSITIONS AS OF DECEMBER 31, 2022 AND 2021 AND, ACCORDINGLY, NO LIABILITY HAS BEEN ACCRUED. 0 0 0 0 0 0 0 0 0 0 MEDICAL MISSION TRIP CENTRAL AMERICA AND THE CARIBBEAN 20 131381 SURGICAL IMPLANT DEVICES RETAIL PRICE 0 0 0 0 0 0 PART III ACCOUNTING METHOD: FORM 990, PART VI, SECTION A, LINE 1A THE OCRI EXECUTIVE COMMITTEE IS MADE UP OF THE (1)CHAIRMAN OF THE BOARD OF DIRECTORS, (2)CHAIRMAN OF THE RESEARCH ADVISORY COMMITTEE AND THE (3)OCRI EXECUTIVE DIRECTOR FORM 990, PART VI, SECTION A, LINE 3 THE EXECUTIVE COMMITTEE IS COMPRISED OF THE CHAIRMAN OF THE BOARD, THE CHAIRMAN OF THE RESEARCH ADVISORY COMMITTEE AND THE EXECUTIVE DIRECTOR. ALL THREE POSITIONS ARE MEMBERS OF THE GOVERNING BOARD.; HOWEVER, THE EXECUTIVE DIRECTOR IS A NON-VOTING EX-OFFICIO MEMBER. FORM 990, PART VI, SECTION B, LINE 11B THE 990 WILL BE REVIEWED BY THE EXECUTIVE DIRECTOR, FOLLOWED BY A REVIEW AND RECOMMENDATION BY THE OCRI FINANCE AND AUDIT COMMITTEE. THE FINAL COPY WITH THE FINANCE AND AUDIT COMMITTEES RECOMMENDATION WILL BE CIRCULATED VIA EMAIL TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE EXECUTIVE DIRECTOR, BOARD MEMBERS AND KEY EMPLOYEES CERTIFY THAT THEY HAVE READ THE ORGANIZATION'S CONFLICT OF INTEREST POLICY AND HAVE DISCLOSED ANY RELATIONSHIPS WITH ANY OF THE ORGANIZATION'S CONTRACTING PARTIES ON THE ORGANIZATIONS CONFLICT OF INTEREST FORM. THE EXECUTIVE DIRECTOR REVIEWS THE CERTIFIED FORMS AND COMPARES IT TO THE PRIOR YEAR'S DISCLOSURES. QUESTIONABLE RELATIONSHIPS ARE NOTED AND BROUGHT TO THE ATTENTION OF THE APPROPRIATE GOVERNANCE GROUP. THE EXECUTIVE DIRECTOR DISCLOSES TO THE FINANCE AND AUDIT COMMITTEE ANY ITEMS THAT AFFECT BUSINESS COMPLIANCE DURING THE NEXT SCHEDULED MEETING AND DISCLOSES CONFLICTS RELATED TO THE RESEARCH TO THE RESEARCH ADVISORY COMMITTEE. APPROPRIATE STEPS ARE TAKEN TO ELIMINATE THE CONFLICT PER COMMITTEE GUIDANCE. FORM 990, PART VI, SECTION B, LINE 15 HUMAN RESOURCES DETERMINES INITIAL COMPENSATION BASED ON MARKET ANALYSIS FOR EXECUTIVE DIRECTOR AND OTHER KEY POSITIONS. THE HUMAN RESOURCE DEPARTMENT ESTABLISHES MIN, MID AND MAX SALARY RANGE FOR ALL POSITIONS IN OCRI BASED ON MARKET ANALYSIS. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2023 FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, THE CONFLICTS OF INTEREST POLICY AND FINANCIALS STATEMENTS ARE PROVIDED UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN BENEFICIAL INTEREST IN POOLED FUNDS -487,484.